Background: Beers criteria are used to identify the potentially inappropriate medications (PIMs) in elderly patients. However, the criteria have limitations such as lacking consideration of drug-drug and duplicated prescriptions. The aim of this study is to compare the efficacy of newly developed screening tool of older person's prescriptions (STOPP) with Beers criteria in identifying PIMs and adverse drug events (ADEs) in elderly patients. Methods: We included 115 elderly patients older than 65 years who visited the outpatients' clinic or have been hospitalized for medical illness. Comprehensive geriatric assessments including medication review by the pharmacists were performed by the multidisciplinary team. Beers criteria and STOPP were used to find out PIMs. The association between PIMs defined by both criteria with ADEs was also evaluated. Results: A total of 59 patients (50.4%) by Beers criteria and 76 patients (65.0%) by STOPP had been prescribed with PIMs. Compared with Beers criteria, STOPP had advantage in identifying more PIMs. In addition, STOPP could identify more ADEs related medications than Beers criteria. STOPP was also useful to detect duplicate drug class prescription and nonsteroidal anti-inflammatory drugs for renal impaired patients. Conclusion: STOPP criteria PIMs can detect more duplicated prescription and are significantly associated with avoidable ADEs in older individuals compared with that of Beers criteria PIMs.
Beers criteria를 이용한 노인 부적절 약물 분석
Beers criteria 적용한 결과, 전체 환자에서 총 110개의 노인 부적절 약물이 58명(50.4%)에서 처방되었다( Table 3) Table 4) . NSAID with heart failure (risk of exacerbation of heart failure) 2 Alphablockers in males with frequent incontinence i.e. one or more episodes of incontinence daily (risk of urinary frequency and worsening of incontinence)
2
Alphablockers with long-term urinary catheter in situ i.e. more than 2 months (drug not indicated) 2 Aspirin at dose >150 mg/day (increased bleeding risk, no evidence for increased efficacy) 1 Aspirin to treat dizziness not clearly attributable to cerebrovascular disease (not indicated) 1 Aspirin, clopidogrel, dipyridamole or warfarin with concurrent bleeding disorder (high risk of bleeding) 1 TCA's with glaucoma (likely to exacerbate glaucoma) 1 TCA's with cardiac conductive abnormalities (pro-arrhythmic effects) 1 TCA's with prostatism or prior history of urinary retention (risk of urinary retention) 1 Anticholinergics to treat extrapyramidal side-effects of neuroleptic medications (risk of anticholinergic toxicity) 1 Non-steroidal anti-inflammatory drug (NSAID) with history of peptic ulcer disease or gastro-intestinal bleeding, unless with concurrent histamine H2-receptor antagonist, PPI or misoprostol (risk of peptic ulcer relapse) STOPP, screening tool of older person's prescriptions; NSAID, nonsteroidal anti-inflammatory drugs; SSRI, selecitve serotonin reuptake inhibitor; ACE, angiotensin converting enzyme; GFR, glomerular filtration rate; TCA, tricylic antidepressants. 
